Literature DB >> 19963083

Hepatocellular carcinoma: current management.

Charles H Cha1, M Wasif Saif, Brett H Yamane, Sharon M Weber.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 19963083     DOI： 10.1067/j.cpsurg.2009.09.003

Source DB:  PubMed          Journal:  Curr Probl Surg        ISSN： 0011-3840            Impact factor:   1.909


× No keyword cloud information.
  18 in total

Review 1.  Combined locoregional treatment of patients with hepatocellular carcinoma: State of the art.

Authors:  Roberto Iezzi; Maurizio Pompili; Alessandro Posa; Giuseppe Coppola; Antonio Gasbarrini; Lorenzo Bonomo
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

2.  Analysis of tissue changes, measurement system effects, and motion artifacts in echo decorrelation imaging.

Authors:  Fong Ming Hooi; Anna Nagle; Swetha Subramanian; T Douglas Mast
Journal:  J Acoust Soc Am       Date:  2015-02       Impact factor: 1.840

3.  Hypermethylation of NF-κB-Activating Protein-Like (NKAPL) Promoter in Hepatocellular Carcinoma Suppresses Its Expression and Predicts a Poor Prognosis.

Authors:  Patrick Kwok Shing Ng; Carol Po Ying Lau; Emily Kai Yee Lam; Sheila Sai Kam Li; Vivian Wai Yan Lui; Winnie Yeo; Yuen Keng Ng; Paul Bo San Lai; Stephen Kwok Wing Tsui
Journal:  Dig Dis Sci       Date:  2018-01-20       Impact factor: 3.199

4.  Dual properties of hispidulin: antiproliferative effects on HepG2 cancer cells and selective inhibition of ABCG2 transport activity.

Authors:  Carina T Scoparo; Glaucio Valdameri; Paulo R Worfel; Fernanda A L B Guterres; Glaucia R Martinez; Sheila M B Winnischofer; Attilio Di Pietro; Maria E M Rocha
Journal:  Mol Cell Biochem       Date:  2015-07-26       Impact factor: 3.396

5.  Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers.

Authors:  Xiao-Wan Bo; Hui-Xiong Xu; Dan Wang; Le-Hang Guo; Li-Ping Sun; Xiao-Long Li; Chong-Ke Zhao; Ya-Ping He; Bo-Ji Liu; Dan-Dan Li; Kun Zhang
Journal:  Br J Radiol       Date:  2016-09-14       Impact factor: 3.039

6.  Helical tomotherapy for single and multiple liver tumours.

Authors:  Tsair-Fwu Lee; Pei-Ju Chao; Fu-Min Fang; Te-Jen Su; Stephen W Leung; Hsuan-Chih Hsu
Journal:  Radiat Oncol       Date:  2010-06-24       Impact factor: 3.481

7.  Nanocapsules: the weapons for novel drug delivery systems.

Authors:  Pavankumar Kothamasu; Hemanth Kanumur; Niranjan Ravur; Chiranjeevi Maddu; Radhika Parasuramrajam; Sivakumar Thangavel
Journal:  Bioimpacts       Date:  2012-04-05

8.  14-3-3ε boosts bleomycin-induced DNA damage response by inhibiting the drug-resistant activity of MVP.

Authors:  Siwei Tang; Chen Bai; Pengyuan Yang; Xian Chen
Journal:  J Proteome Res       Date:  2013-05-09       Impact factor: 4.466

9.  Murine bone marrow stromal cells pulsed with homologous tumor-derived exosomes inhibit proliferation of liver cancer cells.

Authors:  Bo Ma; Hanfang Jiang; Jun Jia; Lijun Di; Guohong Song; Jing Yu; Yulin Zhu; Zhihao Lu; Xiaoli Wang; Xinna Zhou; Jun Ren
Journal:  Clin Transl Oncol       Date:  2012-07-27       Impact factor: 3.405

10.  Lipid nanocapsules loaded with rhenium-188 reduce tumor progression in a rat hepatocellular carcinoma model.

Authors:  Claire Vanpouille-Box; Franck Lacoeuille; Jérôme Roux; Christophe Aubé; Emmanuel Garcion; Nicolas Lepareur; Frédéric Oberti; Francis Bouchet; Nicolas Noiret; Etienne Garin; Jean-Pierre Benoît; Olivier Couturier; François Hindré
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.